Hormone Receptor-positive Metastatic Invasive Lobular Breast Cancer
📧 Sign up to get email alerts when something new happens for Hormone Receptor-positive Metastatic Invasive Lobular Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial) [Phase 2]
Phase II study of repotrectinib with or without fulvestrant in hormone receptor-positive, HER2-negative metastatic invasive lobular breast c…